Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and risk of Parkinson's diseaseMiyuki Hsing-Chun Hsieh,Edward LaiPHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要